Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Interest & Investment Income for 8 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 41.75% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.0 million, a 30.1% decrease, with the full-year FY2024 number at $6.8 million, down 12.01% from a year prior.
  • Interest & Investment Income was $1.0 million for Q3 2025 at Precision Biosciences, down from $1.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.0 million in Q1 2023 to a low of $44000.0 in Q3 2021.
  • A 5-year average of $1.1 million and a median of $1.3 million in 2025 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: plummeted 91.97% in 2021, then skyrocketed 2974.6% in 2022.
  • Precision Biosciences' Interest & Investment Income stood at $63000.0 in 2021, then surged by 2974.6% to $1.9 million in 2022, then dropped by 5.68% to $1.8 million in 2023, then decreased by 18.23% to $1.5 million in 2024, then crashed by 31.26% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Interest & Investment Income are $1.0 million (Q3 2025), $1.1 million (Q2 2025), and $1.3 million (Q1 2025).